Search Results - "Croagh CM"

An immune-based predictive model for HBV clearance: validation in multicenter cohorts and mechanistic insights from in vivo studies.

Authors: Zhang, Rongzheng Qiao, Han Zhou, Kun et al.

Source: Virology Journal. 5/21/2025, Vol. 22 Issue 1, p1-16. 16p.

Methodological considerations in studying natural history of HBeAg-negative and -positive chronic hepatitis B: authors' reply.

Authors: Croagh, Catherine M. N. Bell, Sally J. Desmond, Paul V.

Source: Liver International. Apr2012, Vol. 32 Issue 4, p689-690. 2p.

Letter: Association of persistently high HBsAg levels during HBeAg‐seropositive stage and hepatocellular carcinoma risk in chronic hepatitis B patients.

Authors: Wang, Jian Pan, Yifan Xiong, Ye et al.

Source: Alimentary Pharmacology & Therapeutics. Jun2024, Vol. 59 Issue 11, p1457-1458. 2p.

Dried blood spot sampling for hepatitis B virus quantification, sequencing and mutation detection.

Authors: Bezerra, Cristianne Sousa Portilho, Moyra Machado Barbosa, Jakeline Ribeiro et al.

Source: Scientific Reports. 1/31/2022, Vol. 12 Issue 1, p1-11. 11p.

Relationship between gut microbiome diversity and hepatitis B viral load in patients with chronic hepatitis B.

Authors: Joo, Eun-Jeong Cheong, Hae Suk Kwon, Min-Jung et al.

Source: Gut Pathogens. 10/30/2021, Vol. 13 Issue 1, p1-11. 11p.

Correlation between quantitative HBsAg and quantitative HBV DNA in chronic hepatitis B patients: a systematic review and meta-analysis.

Authors: Maimunah, Ummi Wardhani, Puspa Wungu, Citrawati Dyah Kencono et al.

Source: Egyptian Liver Journal. 5/21/2024, Vol. 14 Issue 1, p1-11. 11p.

A study on outcome of hepatic fibrosis in chronic hepatitis B patients on anti-viral therapy.

Authors: Nag, Avick Ghosh, Saubhik Sarkar, Souvik et al.

Source: Asian Journal of Medical Sciences. Feb2024, Vol. 15 Issue 2, p98-103. 6p.

Prevalence of chronic hepatitis B phases in Eritrean patients: a laboratory-based cross-sectional study.

Authors: Hamida, Mohammed Elfatih Raja, Saud Mohammed Seyoum, Yemane et al.

Source: BMC Gastroenterology. 5/1/2021, Vol. 21 Issue 1, p1-7. 7p.

Genetic diversity, haplotype analysis, and prevalence of Hepatitis B virus MHR mutations among isolates from Kenyan blood donors.

Authors: Langat, Benard Kibet Ochwedo, Kevin Omondi Borlang, Jamie et al.

Source: PLoS ONE. 11/14/2023, Vol. 18 Issue 11, p1-16. 16p.

Hepatitis B virus genotypes and drug resistance mutations circulating in blood donors in Beira, Mozambique.

Authors: Mathew, Ann Ismael, Nalia Meeds, Heidi et al.

Source: PLoS ONE. 2/16/2023, Vol. 18 Issue 2, p1-14. 14p.

The Lamivudine/ Entacavir Resistance Mutations Among Treatment Naïve Chronic HBV Infected Patients Mashhad, Iran.

Authors: Saedi, Elaheh Derakhshan, Mohammad Shamsian, Ali Akbar et al.

Source: Iranian Journal of Medical Microbiology. Sep/Oct2022, Vol. 16 Issue 5, p376-382. 7p.

Effect of FOXP3 gene variants on the immune-active HBV and inactive HBV phases.

Alternate Title: FOXP3 gen varyantlarının immün-aktif HBV ve inaktif HBV fazları üzerindeki etkisi.

Authors: Akgöllü, Ersin¹ ersin0571@gmail.com

Source: Cukurova Medical Journal. 2021, Vol. 46 Issue 4, p1485-1492. 8p.

Chronic inflammation involves CCL11 and IL-13 to facilitate the development of liver cirrhosis and fibrosis in chronic hepatitis B virus infection.

Authors: Wong, Sui-Weng Ting, Yi-Wen Yong, Yean-Kong et al.

Source: Scandinavian Journal of Clinical & Laboratory Investigation. Apr2021, Vol. 81 Issue 2, p147-159. 13p.

Hepatitis B virus precore/core region mutations and genotypes among hepatitis B virus chronic carriers in South-Eastern, Nigeria.

Authors: Mbamalu, Chinenye Ekejindu, Ifeoma Enweani, Ifeoma et al.

Source: Journal of Health Sciences (Qassim University). Mar/Apr2021, Vol. 15 Issue 2, p26-38. 13p.

骨髓来源抑制性细胞在肝脏疾病中的研究进展.

Alternate Title: Research advances in the role of myeloid - derived suppressor cells in liver diseases.

Authors: 徐丽君 安秀琴 李悦 et al.

Source: Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi. Dec2020, Vol. 36 Issue 12, p2851-2855. 5p.

Increasing hepatitis B viral load is associated with risk of significant liver fibrosis in HBeAg-negative but not HBeAg-positive chronic hepatitis B.

Authors: Croagh CM Bell SJ Slavin J et al.

Source: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2010 Sep; Vol. 30 (8), pp. 1115-22. Date of Electronic Publication: 2010 May 21.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101160857 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1478-3231 (Electronic) Linking ISSN: 14783223 NLM ISO Abbreviation: Liver Int Subsets: MEDLINE

HBV DNA level to predict liver fibrosis in HBeAg negative chronic hepatitis B patients with biopsy indication.

Authors: Praneenararat, Surat Chamroonkul, Naichaya Sripongpun, Pimsiri et al.

Source: BMC Gastroenterology. 2014, Vol. 14 Issue 1, p255-268. 14p. 3 Charts.

Evaluation of Cytotoxic T-Lymphocyte Antigen-4 (+49A/G) Gene Polymorphism in Chronic Hepatitis B Virus Infection.

Authors: Mahdi, Yasmin S. Kadhim, Haidar S.

Source: Iraqi Journal of Medical Sciences. 2020, Vol. 18 Issue 2, p101-109. 9p.

Comparative study on guidelines in determining HBV phases in Iranian patients.

Authors: Ashtari, Sara Sharifian, Afsaneh Hatami, Behzad et al.

Source: Gastroenterology & Hepatology from Bed to Bench. 2019 Supplement, Vol. 12, pS145-S148. 4p. 2 Charts.

High prevalence and diversity of hepatitis B and hepatitis delta virus in Gabon.

Authors: Groc, Soraya Abbate, Jessica Lee Le Gal, Frédéric et al.

Source: Journal of Viral Hepatitis. Jan2019, Vol. 26 Issue 1, p170-182. 13p.